(Press-News.org) FINDINGS
Researchers at the UCLA Jonsson Comprehensive Cancer Center have found certain immune cells can still fight cancer even when the cancer cells lack an important protein that the immune system relies on to help track down cancer cells.
The team discovered the absence of the crucial protein B2M seems to activate an alternative immune response involving natural killer (NK) cells and CD4+ T cells in both animal studies and patient tumor biopsies, indicating a potential backup mechanism in the immune system to recognize and attack cancer cells.
BACKGROUND
Immunotherapies, such as immune checkpoint blockade, rely heavily on reactivating CD8+ T cells, which recognize tumor antigens through specific surface molecules on cancer cells. B2M proteins play a key role in this process to help CD8+ T cells identify the cancer cells. However, the researchers noticed that in cases where the B2M protein is missing or significantly reduced, some patients’ cancers can still respond positively to immune checkpoint blockade.
METHOD
To understand this better, the researchers edited the genes of mice with melanoma using CRISPR/CAS9 to make them lose the B2M protein, similar to how some cancer cells lose it. They discovered that in these mice, immune cells —specifically CD4+ T cells and NK cells — could still fight the cancer when given the immunotherapy treatment.
Similarly, in a large cohort of patients with melanoma, they found that tumors lacking proper B2M often displayed an increased presence of activated NK cells, suggesting that these cells might play a vital role in combating cancer when the usual recognition markers are missing.
IMPACT
The study shows that the immune system can still fight certain cancers, like melanoma, even when they lack B2M and thus, CD8+ T cells are rendered less efficient. Understanding these mechanisms could pave the way for the development of more effective combination cancer immunotherapy treatments.
“The unexpected critical role of NK and CD4+ T cells may be yet another way the immune system can combat certain types of tumors with the help of immune checkpoint blockade drugs,” said Mildred Galvez, a MD/PhD student at the David Geffen School of Medicine at UCLA-Charles R. Drew Medical Education Program and co-first author of the study. “This paper is another example of how we can naturally exploit the body's own immune system to figure out which players we need in order to retarget cancer.”
JOURNAL
The study was published in the journal Cancer Immunology Research.
AUTHORS
The senior author is Dr. Antoni Ribas, a professor of medicine and director of the UCLA Jonsson Comprehensive Cancer Center’s Tumor Immunology Program. The study’s other co-first author is Davis Torrejon, a former project scientist in the department of medicine. Other UCLA authors include Gabriel Abril-Rodriguez, Katie M. Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha Kalbasi and Begoña Comin-Anduix.
FUNDING
This work was supported in part by the Parker Institute for Cancer Immunotherapy, grants from the National Institutes of Health and the Ressler Family Fund.
END
Study reveals hidden immune defense against cancer
UCLA researchers uncover new details about how the immune system can recognize and kill cancer cells, unlocking potential new strategies to treat aggressive cancers
2023-11-28
ELSE PRESS RELEASES FROM THIS DATE:
Annals of Family Medicine: papers explore how technology is changing medical practice and how doctors are adapting
2023-11-28
Providence, R.I. – From the ability to conduct clinical visits online to utilizing artificial intelligence to effectively diagnose patients, technology has changed how all doctors practice medicine. One published paper in the November/December issue of Annals of Family Medicine explains how AI-driven technology presents new opportunities for more effective patient care while a second paper describes the interplay between fulfillment of basic psychological needs at work and technology use in maintaining clinician well-being.
In ...
Researchers advance 'placenta-on-a-chip' with sensing, imaging technology
2023-11-28
AMES, Iowa – A research poster dated Dec. 9, 2015, hangs just outside Nicole Hashemi’s Iowa State University laboratory. It introduces a major project for Hashemi and her research group. And it’s evidence that scientific persistence sometimes equals scientific advancement.
Hashemi, an associate professor of mechanical engineering, and her students have been working all these years to develop a “placenta-on-a-chip.” In this case that’s a thin, rectangular, clear, polymer block with two tiny microchannels – just millionths of ...
How neurotransmitters work together to detect and discriminate odors
2023-11-28
A longstanding hypothesis in neurobiology was that a single neuron releases a single type of neurotransmitter, a molecule used by neurons to communicate with one another. In recent decades, several neurons have been found to release more than one neurotransmitter. This phenomenon called co-transmission is increasingly gaining recognition as a powerful and versatile molecular mechanism useful for the dynamic regulation of diverse neural circuits. However, precisely how co-transmission affects the firing of ...
ChargeX Consortium recommends common EV charging station error codes
2023-11-28
New shared language will facilitate faster service, improve EV user experience
The National Charging Experience Consortium (ChargeX) has released a report that recommends 26 common electric vehicle (EV) charging error codes to enable faster error reporting, diagnostics and resolution within the EV charging industry. Ultimately, the codes would improve the U.S. charging experience.
The ChargeX Consortium is a collaboration between U.S. Department of Energy national laboratories, EV charging industry experts, consumer advocates and other stakeholders.
The Recommendations for Minimum Required Error Codes report aims to reduce confusion between charger manufacturers, EV manufacturers and ...
Ending the HIV epidemic may require addressing “everyday” discrimination
2023-11-28
Latino sexual minority men who experience racial, ethnic and sexual prejudice are more likely to delay HIV testing, complicating efforts to end the more than 40-year epidemic, according to a new Rutgers study.
“Total HIV infection rates in the United States are stabilizing, which is good news,” said Gabriel Robles, an assistant professor at the Rutgers School of Social Work and coauthor of the paper published in the journal AIDS Education and Prevention. “What’s bad is that the trend for some subgroups, including some Latino/x sexual minority men, is going in the opposite direction. Our study offers ...
Anonymous $10 million gift to Henry Ford Health establishes lung cancer tissue repository, bolsters research
2023-11-28
As Lung Cancer Awareness Month comes to a close, Henry Ford Health is proud to announce it has received an anonymous gift of $10 million, which is poised to significantly advance lung cancer research at Henry Ford Cancer.
This transformative gift has enabled Henry Ford to establish a new lung cancer tissue biorepository, which is a facility that catalogs and stores biological samples for research. These samples – in this case, lung cancer tissue – are crucial for scientists who are studying ...
RCSI researchers develop material that reduces bacterial infection and speeds up bone healing
2023-11-28
28 November 2023: Researchers at RCSI University of Medicine and Health Sciences and Advanced Materials and Bioengineering Research Centre (AMBER) have developed a new surgical implant that has the potential to transform the treatment of complex bone infections. When implanted on an injured or infected bone, the material can not only speed up bone healing, it also reduces the risk of infections without the need for traditional antibiotics.
The newly published paper in the journal Advanced Materials, tackles the complex clinical problem of bone infection, ...
Contrast sensitivity of ON and OFF human retinal pathways in myopia
2023-11-28
Across the entire animal kingdom, visual images are processed by two major neuronal pathways that extract light and dark stimuli from visual scenes – ON (light on) and OFF (light off) pathways.
Light stimuli are brighter than their background like a white cloud in a gray sky whereas dark stimuli are darker than the background like a black bird in a blue sky. The two pathways can extract stimuli with different contrasts but some pathways are more sensitive than others. In carnivores and rodents, ON pathways are more sensitive ...
DFW air quality continues to miss EPA goals for safety
2023-11-28
Air quality in the Dallas-Fort Worth metropolitan area continues to miss safety levels set by the Environmental Protection Agency (EPA) and is unlikely to meet EPA goals anytime soon, according to new research from The University of Texas at Arlington.
Purnendu “Sandy” Dasgupta, professor of chemistry and biochemistry and the Hamish Small Chair of Ion Analysis at The University of Texas at Arlington, said the region’s low population density, lack of widespread public transportation and reliance on cars contribute to its poor air quality. Its ozone values have exceeded safety levels set by the EPA for the last 20 years.
“Compared ...
Many owners see little value in storing their firearms securely
2023-11-28
With more than 400 million privately owned firearms in circulation across the United States, gun violence prevention efforts have emphasized secure firearm storage as a method for preventing injury and death. But some owners may not see the value in doing so, according to Rutgers researchers.
Despite evidence that secure storage can effectively reduce the risk of suicide and unintentional shootings, many firearm owners typically keep at least one firearm stored loaded and unlocked, quickly accessible in case of home invasion. ...
LAST 30 PRESS RELEASES:
Black youth, especially Black girls, use mental health services less than their White peers
Canada must protect youth from sports betting advertising
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
[Press-News.org] Study reveals hidden immune defense against cancerUCLA researchers uncover new details about how the immune system can recognize and kill cancer cells, unlocking potential new strategies to treat aggressive cancers